While discussing his American Journal of Surgery study, which found a 31-gene expressional profile test can predict outcomes for patients with cutaneous melanoma, John Vetto, M.D., says the test’s results “were independently associated with patient outcomes.

A story discussing FDA commissioner nominees mentions a 2020 JAMA Internal Medicine research letter co-written by OHSU physicians that notes the FDA is steadily accepting more surrogate measures over time, which are not justified by scientific validity or adherence to regulatory precedent. This can lead, they found, to patients’ experiencing “harm and cost without the intended benefit."

In a story about a court order that requires changes to the Snake River Correctional Institution’s COVID-19 protocols, Mark Baskerville, M.D., J.D., says social distancing is nearly impossible in a prison setting.

Amy Hermesch, M.D., Ph.D., says an extremely rare blood-clotting disorder that has been experienced by six people who received the Johnson & Johnson COVID-19 vaccine is more likely to be experienced by pregnant people or women on oral contraceptives.

In a story describing the various ways Portland-area residents can schedule vaccination appointments, Franny White says OHSU released 5,000 new vaccination appointments on April 12, and they were booked within 30 minutes.

While describing OHSU’s collaboration with BridgeBio Pharma, Inc., to research and develop investigational medicines for patients with genetically driven conditions, Peter Barr-Gillespie, Ph.D., says: “We see this collaboration as an important part of our efforts to bring OHSU innovations to clinical significance.”

OHSU will meet its existing vaccination commitments during a pause on the Johnson & Johnson vaccine’s rollout, which was ordered out of an abundance of caution due to reports of an extremely rare blood-clotting condition in six of the 6.8 million Americans who have received it to date.

While discussing a Neurology study that found patients with Parkinson’s who increase physical activity have a modification of an allele that is a major genetic risk factor for cognitive impairment, Jacob Raber, Ph.D., and colleagues wrote in an accompanying editorial that if the results were replicated, they could guide lifestyle interventions.

Sara Courtneidge, Ph.D., is elected a fellow of the American Association for Cancer Research.